 | • レポートコード：D005-13168 • 出版社/出版日：GlobalInfoResearch / 2020年5月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、治療用組換えタンパク質の世界市場を広く調査・分析し、今後の市場展望をまとめております。治療用組換えタンパク質の種類別市場規模（組換えヒトコラージュ、組換えヒト血清アルブミン）、用途別市場規模（医薬品、科学研究、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Boehringer Ingelheim、Regeneron Pharmaceuticals、Eli Liily、Bristol-Myers Squibb、Novartis、Celldex Therapeutics、Takeda、Merck、GlaxoSmithKline、Roche ・地域別グローバル市場分析 2015年-2020年 ・治療用組換えタンパク質の北米市場（アメリカ、カナダ、メキシコ） ・治療用組換えタンパク質のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・治療用組換えタンパク質のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・治療用組換えタンパク質の南米市場（ブラジル、アルゼンチン） ・治療用組換えタンパク質の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：組換えヒトコラージュ、組換えヒト血清アルブミン ・用途別分析：医薬品、科学研究、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Recombinant Therapeutic Protein market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Recombinant Therapeutic Protein market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Recombinant Therapeutic Protein market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Recombinant Therapeutic Protein market has been segmented into
Recombinant Human Collage
Recombinant Human Serum Albumin
By Application, Recombinant Therapeutic Protein has been segmented into:
Medicine
Scientific Research
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Recombinant Therapeutic Protein market presented in the report. This section sheds light on the sales growth of different regional and country-level Recombinant Therapeutic Protein markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Recombinant Therapeutic Protein market.
The report offers in-depth assessment of the growth and other aspects of the Recombinant Therapeutic Protein market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Recombinant Therapeutic Protein Market Share Analysis
Recombinant Therapeutic Protein competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Recombinant Therapeutic Protein sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Recombinant Therapeutic Protein sales, revenue and market share for each player covered in this report.
The major players covered in Recombinant Therapeutic Protein are:
Boehringer Ingelheim
Regeneron Pharmaceuticals
Eli Liily
Bristol-Myers Squibb
Novartis
Celldex Therapeutics
Takeda
Merck
GlaxoSmithKline
Roche
Among other players domestic and global, Recombinant Therapeutic Protein market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Recombinant Therapeutic Protein product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Recombinant Therapeutic Protein, with price, sales, revenue and global market share of Recombinant Therapeutic Protein in 2018 and 2019.
Chapter 3, the Recombinant Therapeutic Protein competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Recombinant Therapeutic Protein breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Recombinant Therapeutic Protein market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Recombinant Therapeutic Protein sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Recombinant Therapeutic Protein Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Recombinant Therapeutic Protein Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Recombinant Human Collage
1.2.3 Recombinant Human Serum Albumin
1.3 Market Analysis by Application
1.3.1 Overview: Global Recombinant Therapeutic Protein Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Medicine
1.3.3 Scientific Research
1.3.4 Others
1.4 Overview of Global Recombinant Therapeutic Protein Market
1.4.1 Global Recombinant Therapeutic Protein Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Boehringer Ingelheim
2.1.1 Boehringer Ingelheim Details
2.1.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Boehringer Ingelheim SWOT Analysis
2.1.4 Boehringer Ingelheim Product and Services
2.1.5 Boehringer Ingelheim Recombinant Therapeutic Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Regeneron Pharmaceuticals
2.2.1 Regeneron Pharmaceuticals Details
2.2.2 Regeneron Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Regeneron Pharmaceuticals SWOT Analysis
2.2.4 Regeneron Pharmaceuticals Product and Services
2.2.5 Regeneron Pharmaceuticals Recombinant Therapeutic Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Eli Liily
2.3.1 Eli Liily Details
2.3.2 Eli Liily Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Eli Liily SWOT Analysis
2.3.4 Eli Liily Product and Services
2.3.5 Eli Liily Recombinant Therapeutic Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Bristol-Myers Squibb
2.4.1 Bristol-Myers Squibb Details
2.4.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Bristol-Myers Squibb SWOT Analysis
2.4.4 Bristol-Myers Squibb Product and Services
2.4.5 Bristol-Myers Squibb Recombinant Therapeutic Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Novartis SWOT Analysis
2.5.4 Novartis Product and Services
2.5.5 Novartis Recombinant Therapeutic Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Celldex Therapeutics
2.6.1 Celldex Therapeutics Details
2.6.2 Celldex Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Celldex Therapeutics SWOT Analysis
2.6.4 Celldex Therapeutics Product and Services
2.6.5 Celldex Therapeutics Recombinant Therapeutic Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Takeda
2.7.1 Takeda Details
2.7.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Takeda SWOT Analysis
2.7.4 Takeda Product and Services
2.7.5 Takeda Recombinant Therapeutic Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Merck
2.8.1 Merck Details
2.8.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Merck SWOT Analysis
2.8.4 Merck Product and Services
2.8.5 Merck Recombinant Therapeutic Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 GlaxoSmithKline
2.9.1 GlaxoSmithKline Details
2.9.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 GlaxoSmithKline SWOT Analysis
2.9.4 GlaxoSmithKline Product and Services
2.9.5 GlaxoSmithKline Recombinant Therapeutic Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Roche
2.10.1 Roche Details
2.10.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Roche SWOT Analysis
2.10.4 Roche Product and Services
2.10.5 Roche Recombinant Therapeutic Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Recombinant Therapeutic Protein Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Recombinant Therapeutic Protein Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Recombinant Therapeutic Protein Manufacturer Market Share in 2019
3.3.2 Top 6 Recombinant Therapeutic Protein Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Recombinant Therapeutic Protein Sales, Revenue and Market Share by Regions
4.1.1 Global Recombinant Therapeutic Protein Sales and Market Share by Regions (2015-2020)
4.1.2 Global Recombinant Therapeutic Protein Revenue and Market Share by Regions (2015-2020)
4.2 North America Recombinant Therapeutic Protein Sales and Growth Rate (2015-2020)
4.3 Europe Recombinant Therapeutic Protein Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Recombinant Therapeutic Protein Sales and Growth Rate (2015-2020)
4.5 South America Recombinant Therapeutic Protein Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Recombinant Therapeutic Protein Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Recombinant Therapeutic Protein Sales, Revenue and Market Share by Country
5.1.1 North America Recombinant Therapeutic Protein Sales and Market Share by Country (2015-2020)
5.1.2 North America Recombinant Therapeutic Protein Revenue and Market Share by Country (2015-2020)
5.2 United States Recombinant Therapeutic Protein Sales and Growth Rate (2015-2020)
5.3 Canada Recombinant Therapeutic Protein Sales and Growth Rate (2015-2020)
5.4 Mexico Recombinant Therapeutic Protein Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Recombinant Therapeutic Protein Sales, Revenue and Market Share by Country
6.1.1 Europe Recombinant Therapeutic Protein Sales and Market Share by Country (2015-2020)
6.1.2 Europe Recombinant Therapeutic Protein Revenue and Market Share by Country (2015-2020)
6.2 Germany Recombinant Therapeutic Protein Sales and Growth Rate (2015-2020)
6.3 UK Recombinant Therapeutic Protein Sales and Growth Rate (2015-2020)
6.4 France Recombinant Therapeutic Protein Sales and Growth Rate (2015-2020)
6.5 Russia Recombinant Therapeutic Protein Sales and Growth Rate (2015-2020)
6.6 Italy Recombinant Therapeutic Protein Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Recombinant Therapeutic Protein Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Recombinant Therapeutic Protein Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Recombinant Therapeutic Protein Revenue and Market Share by Regions (2015-2020)
7.2 China Recombinant Therapeutic Protein Sales and Growth Rate (2015-2020)
7.3 Japan Recombinant Therapeutic Protein Sales and Growth Rate (2015-2020)
7.4 Korea Recombinant Therapeutic Protein Sales and Growth Rate (2015-2020)
7.5 India Recombinant Therapeutic Protein Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Recombinant Therapeutic Protein Sales and Growth Rate (2015-2020)
7.7 Australia Recombinant Therapeutic Protein Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Recombinant Therapeutic Protein Sales, Revenue and Market Share by Country
8.1.1 South America Recombinant Therapeutic Protein Sales and Market Share by Country (2015-2020)
8.1.2 South America Recombinant Therapeutic Protein Revenue and Market Share by Country (2015-2020)
8.2 Brazil Recombinant Therapeutic Protein Sales and Growth Rate (2015-2020)
8.3 Argentina Recombinant Therapeutic Protein Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Recombinant Therapeutic Protein Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Recombinant Therapeutic Protein Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Recombinant Therapeutic Protein Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Recombinant Therapeutic Protein Sales and Growth Rate (2015-2020)
9.3 Turkey Recombinant Therapeutic Protein Sales and Growth Rate (2015-2020)
9.4 Egypt Recombinant Therapeutic Protein Sales and Growth Rate (2015-2020)
9.5 South Africa Recombinant Therapeutic Protein Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Recombinant Therapeutic Protein Sales and Market Share by Type (2015-2020)
10.2 Global Recombinant Therapeutic Protein Revenue and Market Share by Type (2015-2020)
10.3 Global Recombinant Therapeutic Protein Price by Type (2015-2020)
11 Global Recombinant Therapeutic Protein Market Segment by Application
11.1 Global Recombinant Therapeutic Protein Sales Market Share by Application (2015-2020)
11.2 Global Recombinant Therapeutic Protein Revenue Market Share by Application (2015-2020)
11.3 Global Recombinant Therapeutic Protein Price by Application (2015-2020)
12 Market Forecast
12.1 Global Recombinant Therapeutic Protein Sales, Revenue and Growth Rate (2021-2025)
12.2 Recombinant Therapeutic Protein Market Forecast by Regions (2021-2025)
12.2.1 North America Recombinant Therapeutic Protein Market Forecast (2021-2025)
12.2.2 Europe Recombinant Therapeutic Protein Market Forecast (2021-2025)
12.2.3 Asia-Pacific Recombinant Therapeutic Protein Market Forecast (2021-2025)
12.2.4 South America Recombinant Therapeutic Protein Market Forecast (2021-2025)
12.2.5 Middle East & Africa Recombinant Therapeutic Protein Market Forecast (2021-2025)
12.3 Recombinant Therapeutic Protein Market Forecast by Type (2021-2025)
12.3.1 Global Recombinant Therapeutic Protein Sales Forecast by Type (2021-2025)
12.3.2 Global Recombinant Therapeutic Protein Market Share Forecast by Type (2021-2025)
12.4 Recombinant Therapeutic Protein Market Forecast by Application (2021-2025)
12.4.1 Global Recombinant Therapeutic Protein Sales Forecast by Application (2021-2025)
12.4.2 Global Recombinant Therapeutic Protein Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Recombinant Therapeutic Protein Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Recombinant Therapeutic Protein by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Recombinant Therapeutic Protein Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 8. Boehringer Ingelheim Recombinant Therapeutic Protein Major Business
Table 9. Boehringer Ingelheim Recombinant Therapeutic Protein Total Revenue (USD Million) (2018-2019)
Table 10. Boehringer Ingelheim SWOT Analysis
Table 11. Boehringer Ingelheim Recombinant Therapeutic Protein Product and Services
Table 12. Boehringer Ingelheim Recombinant Therapeutic Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Regeneron Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 14. Regeneron Pharmaceuticals Recombinant Therapeutic Protein Major Business
Table 15. Regeneron Pharmaceuticals Recombinant Therapeutic Protein Total Revenue (USD Million) (2018-2019)
Table 16. Regeneron Pharmaceuticals SWOT Analysis
Table 17. Regeneron Pharmaceuticals Recombinant Therapeutic Protein Product and Services
Table 18. Regeneron Pharmaceuticals Recombinant Therapeutic Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Eli Liily Basic Information, Manufacturing Base and Competitors
Table 20. Eli Liily Recombinant Therapeutic Protein Major Business
Table 21. Eli Liily Recombinant Therapeutic Protein Total Revenue (USD Million) (2018-2019)
Table 22. Eli Liily SWOT Analysis
Table 23. Eli Liily Recombinant Therapeutic Protein Product and Services
Table 24. Eli Liily Recombinant Therapeutic Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 26. Bristol-Myers Squibb Recombinant Therapeutic Protein Major Business
Table 27. Bristol-Myers Squibb Recombinant Therapeutic Protein Total Revenue (USD Million) (2018-2019)
Table 28. Bristol-Myers Squibb SWOT Analysis
Table 29. Bristol-Myers Squibb Recombinant Therapeutic Protein Product and Services
Table 30. Bristol-Myers Squibb Recombinant Therapeutic Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Novartis Basic Information, Manufacturing Base and Competitors
Table 32. Novartis Recombinant Therapeutic Protein Major Business
Table 33. Novartis Recombinant Therapeutic Protein Total Revenue (USD Million) (2018-2019)
Table 34. Novartis SWOT Analysis
Table 35. Novartis Recombinant Therapeutic Protein Product and Services
Table 36. Novartis Recombinant Therapeutic Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Celldex Therapeutics Basic Information, Manufacturing Base and Competitors
Table 38. Celldex Therapeutics Recombinant Therapeutic Protein Major Business
Table 39. Celldex Therapeutics Recombinant Therapeutic Protein Total Revenue (USD Million) (2018-2019)
Table 40. Celldex Therapeutics SWOT Analysis
Table 41. Celldex Therapeutics Recombinant Therapeutic Protein Product and Services
Table 42. Celldex Therapeutics Recombinant Therapeutic Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Takeda Basic Information, Manufacturing Base and Competitors
Table 44. Takeda Recombinant Therapeutic Protein Major Business
Table 45. Takeda Recombinant Therapeutic Protein Total Revenue (USD Million) (2018-2019)
Table 46. Takeda SWOT Analysis
Table 47. Takeda Recombinant Therapeutic Protein Product and Services
Table 48. Takeda Recombinant Therapeutic Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Merck Basic Information, Manufacturing Base and Competitors
Table 50. Merck Recombinant Therapeutic Protein Major Business
Table 51. Merck Recombinant Therapeutic Protein Total Revenue (USD Million) (2018-2019)
Table 52. Merck SWOT Analysis
Table 53. Merck Recombinant Therapeutic Protein Product and Services
Table 54. Merck Recombinant Therapeutic Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 56. GlaxoSmithKline Recombinant Therapeutic Protein Major Business
Table 57. GlaxoSmithKline Recombinant Therapeutic Protein Total Revenue (USD Million) (2018-2019)
Table 58. GlaxoSmithKline SWOT Analysis
Table 59. GlaxoSmithKline Recombinant Therapeutic Protein Product and Services
Table 60. GlaxoSmithKline Recombinant Therapeutic Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Roche Basic Information, Manufacturing Base and Competitors
Table 62. Roche Recombinant Therapeutic Protein Major Business
Table 63. Roche Recombinant Therapeutic Protein Total Revenue (USD Million) (2018-2019)
Table 64. Roche SWOT Analysis
Table 65. Roche Recombinant Therapeutic Protein Product and Services
Table 66. Roche Recombinant Therapeutic Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Global Recombinant Therapeutic Protein Sales by Manufacturer (2018-2019) (K MT)
Table 68. Global Recombinant Therapeutic Protein Revenue by Manufacturer (2018-2019) (USD Million)
Table 69. Global Recombinant Therapeutic Protein Sales by Regions (2015-2020) (K MT)
Table 70. Global Recombinant Therapeutic Protein Sales Market Share by Regions (2015-2020)
Table 71. Global Recombinant Therapeutic Protein Revenue by Regions (2015-2020) (USD Million)
Table 72. North America Recombinant Therapeutic Protein Sales by Countries (2015-2020) (K MT)
Table 73. North America Recombinant Therapeutic Protein Sales Market Share by Countries (2015-2020)
Table 74. North America Recombinant Therapeutic Protein Revenue by Countries (2015-2020) (USD Million)
Table 75. North America Recombinant Therapeutic Protein Revenue Market Share by Countries (2015-2020)
Table 76. Europe Recombinant Therapeutic Protein Sales by Countries (2015-2020) (K MT)
Table 77. Europe Recombinant Therapeutic Protein Sales Market Share by Countries (2015-2020)
Table 78. Europe Recombinant Therapeutic Protein Revenue by Countries (2015-2020) (USD Million)
Table 79. Asia-Pacific Recombinant Therapeutic Protein Sales by Regions (2015-2020) (K MT)
Table 80. Asia-Pacific Recombinant Therapeutic Protein Sales Market Share by Regions (2015-2020)
Table 81. Asia-Pacific Recombinant Therapeutic Protein Revenue by Regions (2015-2020) (USD Million)
Table 82. South America Recombinant Therapeutic Protein Sales by Countries (2015-2020) (K MT)
Table 83. South America Recombinant Therapeutic Protein Sales Market Share by Countries (2015-2020)
Table 84. South America Recombinant Therapeutic Protein Revenue by Countries (2015-2020) (USD Million)
Table 85. South America Recombinant Therapeutic Protein Revenue Market Share by Countries (2015-2020)
Table 86. Middle East & Africa Recombinant Therapeutic Protein Sales by Countries (2015-2020) (K MT)
Table 87. Middle East & Africa Recombinant Therapeutic Protein Sales Market Share by Countries (2015-2020)
Table 88. Middle East & Africa Recombinant Therapeutic Protein Revenue by Countries (2015-2020) (USD Million)
Table 89. Middle East & Africa Recombinant Therapeutic Protein Revenue Market Share by Countries (2015-2020)
Table 90. Global Recombinant Therapeutic Protein Sales by Type (2015-2020) (K MT)
Table 91. Global Recombinant Therapeutic Protein Sales Share by Type (2015-2020)
Table 92. Global Recombinant Therapeutic Protein Revenue by Type (2015-2020) (USD Million)
Table 93. Global Recombinant Therapeutic Protein Revenue Share by Type (2015-2020)
Table 94. Global Recombinant Therapeutic Protein Sales by Application (2015-2020) (K MT)
Table 95. Global Recombinant Therapeutic Protein Sales Share by Application (2015-2020)
Table 96. Global Recombinant Therapeutic Protein Sales Forecast by Regions (2021-2025) (K MT)
Table 97. Global Recombinant Therapeutic Protein Market Share Forecast by Regions (2021-2025)
Table 98. Global Recombinant Therapeutic Protein Sales Forecast by Type (2021-2025) (K MT)
Table 99. Global Recombinant Therapeutic Protein Market Share Forecast by Type (2021-2025)
Table 100. Global Recombinant Therapeutic Protein Sales Forecast by Application (2021-2025)
Table 101. Global Recombinant Therapeutic Protein Market Share Forecast by Application (2021-2025)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Recombinant Therapeutic Protein Picture
Figure 2. Global Sales Market Share of Recombinant Therapeutic Protein by Type in 2019
Figure 3. Recombinant Human Collage Picture
Figure 4. Recombinant Human Serum Albumin Picture
Figure 5. Recombinant Therapeutic Protein Sales Market Share by Application in 2018
Figure 6. Medicine Picture
Figure 7. Scientific Research Picture
Figure 8. Others Picture
Figure 9. Global Recombinant Therapeutic Protein Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Recombinant Therapeutic Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Recombinant Therapeutic Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Recombinant Therapeutic Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Recombinant Therapeutic Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Recombinant Therapeutic Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Recombinant Therapeutic Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Recombinant Therapeutic Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Recombinant Therapeutic Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Recombinant Therapeutic Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Recombinant Therapeutic Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Recombinant Therapeutic Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Recombinant Therapeutic Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Recombinant Therapeutic Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Recombinant Therapeutic Protein Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Recombinant Therapeutic Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Recombinant Therapeutic Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Recombinant Therapeutic Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Recombinant Therapeutic Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Recombinant Therapeutic Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Recombinant Therapeutic Protein Sales Market Share by Manufacturer in 2019
Figure 30. Global Recombinant Therapeutic Protein Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Recombinant Therapeutic Protein Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Recombinant Therapeutic Protein Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Recombinant Therapeutic Protein Sales and Growth Rate (2015-2020) (K MT)
Figure 35. Global Recombinant Therapeutic Protein Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Recombinant Therapeutic Protein Revenue Market Share by Regions (2015-2020)
Figure 37. Global Recombinant Therapeutic Protein Revenue Market Share by Regions in 2018
Figure 38. North America Recombinant Therapeutic Protein Sales and Growth Rate (2015-2020)
Figure 39. Europe Recombinant Therapeutic Protein Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Recombinant Therapeutic Protein Sales and Growth Rate (2015-2020)
Figure 41. South America Recombinant Therapeutic Protein Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Recombinant Therapeutic Protein Sales and Growth Rate (2015-2020)
Figure 43. North America Recombinant Therapeutic Protein Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Recombinant Therapeutic Protein Sales Market Share by Countries (2015-2020)
Figure 45. North America Recombinant Therapeutic Protein Sales Market Share by Countries in 2018
Figure 46. North America Recombinant Therapeutic Protein Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Recombinant Therapeutic Protein Revenue Market Share by Countries in 2018
Figure 48. United States Recombinant Therapeutic Protein Sales and Growth Rate (2015-2020) (K MT)
Figure 49. Canada Recombinant Therapeutic Protein Sales and Growth Rate (2015-2020) (K MT)
Figure 50. Mexico Recombinant Therapeutic Protein Sales and Growth Rate (2015-2020) (K MT)
Figure 51. Europe Recombinant Therapeutic Protein Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Recombinant Therapeutic Protein Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Recombinant Therapeutic Protein Revenue Market Share by Countries in 2019
Figure 54. Germany Recombinant Therapeutic Protein Sales and Growth Rate (2015-2020) (K MT)
Figure 55. UK Recombinant Therapeutic Protein Sales and Growth Rate (2015-2020) (K MT)
Figure 56. France Recombinant Therapeutic Protein Sales and Growth Rate (2015-2020) (K MT)
Figure 57. Russia Recombinant Therapeutic Protein Sales and Growth Rate (2015-2020) (K MT)
Figure 58. Italy Recombinant Therapeutic Protein Sales and Growth Rate (2015-2020) (K MT)
Figure 59. Asia-Pacific Recombinant Therapeutic Protein Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Recombinant Therapeutic Protein Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Recombinant Therapeutic Protein Revenue Market Share by Regions 2019
Figure 62. China Recombinant Therapeutic Protein Sales and Growth Rate (2015-2020) (K MT)
Figure 63. Japan Recombinant Therapeutic Protein Sales and Growth Rate (2015-2020) (K MT)
Figure 64. Korea Recombinant Therapeutic Protein Sales and Growth Rate (2015-2020) (K MT)
Figure 65. India Recombinant Therapeutic Protein Sales and Growth Rate (2015-2020) (K MT)
Figure 66. Southeast Asia Recombinant Therapeutic Protein Sales and Growth Rate (2015-2020) (K MT)
Figure 67. South America Recombinant Therapeutic Protein Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Recombinant Therapeutic Protein Sales Market Share by Countries in 2019
Figure 69. South America Recombinant Therapeutic Protein Revenue Market Share by Countries in 2019
Figure 70. Brazil Recombinant Therapeutic Protein Sales and Growth Rate (2015-2020) (K MT)
Figure 71. Argentina Recombinant Therapeutic Protein Sales and Growth Rate (2015-2020) (K MT)
Figure 72. Middle East and Africa Recombinant Therapeutic Protein Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Recombinant Therapeutic Protein Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Recombinant Therapeutic Protein Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Recombinant Therapeutic Protein Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Recombinant Therapeutic Protein Sales and Growth Rate (2015-2020) (K MT)
Figure 77. Egypt Recombinant Therapeutic Protein Sales and Growth Rate (2015-2020) (K MT)
Figure 78. Turkey Recombinant Therapeutic Protein Sales and Growth Rate (2015-2020) (K MT)
Figure 79. South Africa Recombinant Therapeutic Protein Sales and Growth Rate (2015-2020) (K MT)
Figure 80. Global Recombinant Therapeutic Protein Sales and Growth Rate (2021-2025) (K MT)
Figure 81. Global Recombinant Therapeutic Protein Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Recombinant Therapeutic Protein Market Forecast (2021-2025) (K MT)
Figure 83. Europe Sales Recombinant Therapeutic Protein Market Forecast (2021-2025) (K MT)
Figure 84. Asia-Pacific Sales Recombinant Therapeutic Protein Market Forecast (2021-2025) (K MT)
Figure 85. South America Sales Recombinant Therapeutic Protein Market Forecast (2021-2025) (K MT)
Figure 86. Middle East & Africa Sales Recombinant Therapeutic Protein Market Forecast (2021-2025) (K MT)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
組換えヒトエンドスタチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Recombinant Human Endostatin market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Recombinant Huma…- 組換えグリコシル化タンパク質の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Recombinant Glycosylated Protein market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Recombinant …
- 組み換え非グリコシル化タンパク質の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Recombinant Non-glycosylated Protein market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Recombin…
- 組換えタンパク質薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Recombinant Protein Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Recombinant Protein…
- 組換えワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Recombinant Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.3% in the forecast period of 2020 to 2025 and will expected to reach USD 935.1 million by 2025, from USD 822.7 million in 2019. The Recombinant Vacci…